Related references
Note: Only part of the references are listed.CD8+ T Effector Memory Cells Protect against Liver-Stage Malaria
Arturo Reyes-Sandoval et al.
JOURNAL OF IMMUNOLOGY (2011)
The HIV/AIDS Vaccine Candidate MVA-B Administered as a Single Immunogen in Humans Triggers Robust, Polyfunctional, and Selective Effector Memory T Cell Responses to HIV-1 Antigens
Carmen Elena Gomez et al.
JOURNAL OF VIROLOGY (2011)
Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial
Ally Olotu et al.
LANCET INFECTIOUS DISEASES (2011)
First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children
Selidji Todagbe Agnandji et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Circumsporozoite-Specific T Cell Responses in Children Vaccinated with RTS,S/AS01E and Protection against P falciparum Clinical Malaria
Ally Olotu et al.
PLOS ONE (2011)
A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccine
David W. Porter et al.
VACCINE (2011)
Prime-boost vectored malaria vaccines Progress and prospects
Adrian V. S. Hill et al.
HUMAN VACCINES (2010)
Malaria Vaccine Design: Immunological Considerations
Michael F. Good et al.
IMMUNITY (2010)
Prime-Boost Immunization with Adenoviral and Modified Vaccinia Virus Ankara Vectors Enhances the Durability and Polyfunctionality of Protective Malaria CD8(+) T-Cell Responses
Arturo Reyes-Sandoval et al.
INFECTION AND IMMUNITY (2010)
Immunogenic Profiling in Mice of a HIV/AIDS Vaccine Candidate (MVA-B) Expressing Four HIV-1 Antigens and Potentiation by Specific Gene Deletions
Juan Garcia-Arriaza et al.
PLOS ONE (2010)
Plasmodium falciparum-Specific Cellular Immune Responses after Immunization with the RTS,S/AS02D Candidate Malaria Vaccine in Infants Living in an Area of High Endemicity in Mozambique
Arnoldo Barbosa et al.
INFECTION AND IMMUNITY (2009)
Innate Immune Sensing of Modified Vaccinia Virus Ankara (MVA) Is Mediated by TLR2-TLR6, MDA-5 and the NALP3 Inflammasome
Julie Delaloye et al.
PLOS PATHOGENS (2009)
The poxvirus vectors MVA and NYVAC as gene delivery systems for vaccination against infectious diseases and cancer
Carmen E. Gomez et al.
CURRENT GENE THERAPY (2008)
Protective CD8(+) T cells against Plasmodium liver stages: immunobiology of an 'unnatural' immune response
Michael Glen Overstreet et al.
IMMUNOLOGICAL REVIEWS (2008)
Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naive adults at the Walter Reed Army Institute of Research
Kent E. Kester et al.
VACCINE (2008)
Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique:: a double blind randomised controlled phase I/IIb trial
John J. Aponte et al.
LANCET (2007)
Distinct gene expression profiling after infection of immature human monocyte-derived dendritic cells by the attenuated poxvirus vectors MVA and NYVAC
Susana Guerra et al.
JOURNAL OF VIROLOGY (2007)
A novel recombinant virus-like particle vaccine for prevention of porcine parvovirus-induced reproductive failure
Adriaan F. G. Antonis et al.
VACCINE (2006)
Influence of flanking sequences on presentation efficiency of a CD8+ cytotoxic T-cell epitope delivered by parvovirus-like particles
P Rueda et al.
JOURNAL OF GENERAL VIROLOGY (2004)
Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children:: randomised controlled trial
PL Alonso et al.
LANCET (2004)
Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against human immunodeficiency virus Env protein systemically and in the genitorectal draining lymph nodes
MM Gherardi et al.
JOURNAL OF VIROLOGY (2003)
Induction of protective immunity against malaria by priming-boosting immunization with recombinant cold-adapted influenza and modified vaccinia Ankara viruses expressing a CD8(+)-T-cell epitope derived from the circumsporozoite protein of Plasmodium yoelii
G Gonzalez-Aseguinolaza et al.
JOURNAL OF VIROLOGY (2003)
CD8α- CD11b+ dendritic cells present exogenous virus-like particles to CD8+ T cells and subsequently express CD8α and CD205 molecules
G Morón et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
In vivo induction of a high-avidity, high-frequency cytotoxic T-lymphocyte response is associated with antiviral protective immunity
C Sedlik et al.
JOURNAL OF VIROLOGY (2000)